Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $7.22 in the prior trading day, Mind Medicine Inc (NASDAQ: MNMD) closed at $7.25, up 0.49%. In other words, the price has increased by $0.49 from its previous closing price. On the day, 1.19 million shares were traded. MNMD stock price reached its highest trading level at $7.43 during the session, while it also had its lowest trading level at $7.05.
Ratios:
Our goal is to gain a better understanding of MNMD by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.91 and its Current Ratio is at 3.91. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.07.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Robert W. Baird on May 29, 2024, initiated with a Outperform rating and assigned the stock a target price of $27.
On April 15, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $20.
On December 05, 2023, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $9.Canaccord Genuity initiated its Buy rating on December 05, 2023, with a $9 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 25 ’24 when Barrow Robert sold 16,519 shares for $9.50 per share. The transaction valued at 156,930 led to the insider holds 580,202 shares of the business.
Karlin Dan sold 6,578 shares of MNMD for $62,491 on Mar 25 ’24. The Chief Medical Officer now owns 358,452 shares after completing the transaction at $9.50 per share. On Dec 26 ’23, another insider, Barrow Robert, who serves as the Chief Executive Officer of the company, sold 13,237 shares for $3.63 each. As a result, the insider received 48,050 and left with 596,721 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MNMD now has a Market Capitalization of 521074912 and an Enterprise Value of 282933056.
Stock Price History:
Over the past 52 weeks, MNMD has reached a high of $12.22, while it has fallen to a 52-week low of $2.41. The 50-Day Moving Average of the stock is -20.85%, while the 200-Day Moving Average is calculated to be 33.53%.
Shares Statistics:
The stock has traded on average 2.49M shares per day over the past 3-months and 1844750 shares per day over the last 10 days, according to various share statistics. A total of 41.10M shares are outstanding, with a floating share count of 27.40M. Insiders hold about 2.71% of the company’s shares, while institutions hold 119.76% stake in the company. Shares short for MNMD as of 1715731200 were 6133922 with a Short Ratio of 2.46, compared to 1713139200 on 6924134. Therefore, it implies a Short% of Shares Outstanding of 6133922 and a Short% of Float of 8.540000000000001.
